Who are Fusidic Acid 1%'s main competitors?

Direct comparators (same drug class / molecular target / therapeutic area): Fucidin® cream.

How often does this brief refresh?

Every 30 minutes from primary sources (FDA, EMA, MHRA, PMDA, ClinicalTrials.gov, USPTO). Subscribe to the RSS feed below for push alerts.

How do I get this as a recurring report?

Subscribe to /feed/ci/fusidic-acid-1.xml in any RSS reader (Feedly, Inoreader, NewsBlur). Every regulatory action, trial readout, or patent event lands in your feed automatically.

Last reviewed 2026-05-14 · How we verify

Fusidic Acid 1% — Competitive Intelligence Brief

Fusidic Acid 1% (Fusidic Acid 1%) competitive landscape: 1 comparator, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Steroid antibiotic. Area: Infectious Disease.

phase 3 Steroid antibiotic Bacterial elongation factor G (EF-G) Infectious Disease Small molecule Live · refreshed every 30 min

Target snapshot

Fusidic Acid 1% (Fusidic Acid 1%) — Baxis Pharmaceuticals, Inc.. Fusidic acid inhibits bacterial protein synthesis by binding to elongation factor G and preventing peptide chain elongation.

Comparator set (1 drugs)

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

Drug	Generic	Sponsor	Phase	Class	Target	Approval / PDUFA
Fusidic Acid 1% TARGET	Fusidic Acid 1%	Baxis Pharmaceuticals, Inc.	phase 3	Steroid antibiotic	Bacterial elongation factor G (EF-G)
Fucidin® cream	Fucidin® cream	LEO Pharma	marketed	Steroid antibiotic	Bacterial elongation factor G (EF-G)

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Steroid antibiotic class)

Baxis Pharmaceuticals, Inc. · 1 drug in this class
LEO Pharma · 1 drug in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). Fusidic Acid 1% — Competitive Intelligence Brief. https://druglandscape.com/ci/fusidic-acid-1. Accessed 2026-05-14.

Build your own brief

Pick any drug + add comparators:

https://druglandscape.com/ci/{slug} — auto-detected competitors
https://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3 — explicit comparators
Brand names auto-resolve: /ci/keytruda → 301 → /ci/pembrolizumab